Published in Arterioscler Thromb Vasc Biol on September 14, 2006
Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol (2009) 5.28
Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res (2008) 3.16
The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov (2008) 2.90
The role of the adventitia in vascular inflammation. Cardiovasc Res (2007) 2.21
Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. BMC Med Genomics (2011) 1.37
CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis. Circ Res (2008) 1.26
The role of interleukin-18 in the metabolic syndrome. Cardiovasc Diabetol (2010) 1.23
Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. J Clin Invest (2007) 1.19
Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev (2010) 1.18
Neointimal hyperplasia associated with synthetic hemodialysis grafts. Kidney Int (2008) 1.18
Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases. Endocr Rev (2012) 1.11
T cells in arteritis and atherosclerosis. Curr Opin Lipidol (2008) 1.10
Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome. Mediators Inflamm (2014) 1.10
Targeted deletions of cyclooxygenase-2 and atherogenesis in mice. Circulation (2010) 1.04
Mechanisms involved in the association between periodontal diseases and cardiovascular disease. Oral Dis (2011) 1.00
Circulating Th22 and Th9 levels in patients with acute coronary syndrome. Mediators Inflamm (2013) 0.99
Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial. J Cardiovasc Transl Res (2012) 0.97
Vaccination against atherosclerosis? Induction of atheroprotective immunity. Semin Immunopathol (2009) 0.97
Mast cells in vulnerable atherosclerotic plaques--a view to a kill. J Cell Mol Med (2007) 0.96
Immune response to lipoproteins in atherosclerosis. Cholesterol (2012) 0.90
Beyond vascular inflammation--recent advances in understanding atherosclerosis. Cell Mol Life Sci (2015) 0.90
VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis. Clin Exp Immunol (2014) 0.89
P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall. Trends Cardiovasc Med (2009) 0.84
The downstream regulation of chemokine receptor signalling: implications for atherosclerosis. Mediators Inflamm (2013) 0.83
Inhibition of IFN regulatory factor-1 down-regulate Th1 cell function in patients with acute coronary syndrome. J Clin Immunol (2010) 0.83
Characterization of CD8(+)CD57(+) T cells in patients with acute myocardial infarction. Cell Mol Immunol (2014) 0.82
Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling. PLoS One (2013) 0.82
Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice. Cell Mol Immunol (2013) 0.82
Overexpression of TGF-ß1 in macrophages reduces and stabilizes atherosclerotic plaques in ApoE-deficient mice. PLoS One (2012) 0.81
The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis. J Biomed Biotechnol (2011) 0.81
Statins impair CD1d-mediated antigen presentation through the inhibition of prenylation. J Immunol (2009) 0.81
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease. Oncotarget (2016) 0.81
Valsartan Attenuates Atherosclerosis via Upregulating the Th2 Immune Response in Prolonged Angiotensin II-Treated ApoE(-/-) Mice. Mol Med (2015) 0.80
Regulation of atherogenesis by chemokines and chemokine receptors. Arch Immunol Ther Exp (Warsz) (2012) 0.80
Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals. Mediators Inflamm (2015) 0.80
Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis. Semin Immunopathol (2009) 0.79
Serum from exercising humans suppresses t-cell cytokine production. Cytokine (2007) 0.79
Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis. Immunobiology (2011) 0.79
Cholesterol and hematopoietic stem cells: inflammatory mediators of atherosclerosis. Stem Cells Transl Med (2014) 0.78
Data mining of atherosclerotic plaque transcriptomes predicts STAT1-dependent inflammatory signal integration in vascular disease. Int J Mol Sci (2014) 0.78
Regulation of atherogenesis by chemokine receptor CCR6. Trends Cardiovasc Med (2011) 0.77
Correlation of interleukin-17-producing effector memory T cells and CD4+CD25+Foxp3 regulatory T cells with the phosphate levels in chronic hemodialysis patients. ScientificWorldJournal (2014) 0.77
C-Peptide in the vessel wall. Rev Diabet Stud (2009) 0.77
Identification of candidate genes involved in coronary artery calcification by transcriptome sequencing of cell lines. BMC Genomics (2014) 0.77
Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses. Arterioscler Thromb Vasc Biol (2014) 0.77
Differential expression of T cell-related genes in AMI and SA stages of coronary artery disease. Int J Clin Exp Med (2015) 0.76
Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology. PLoS One (2014) 0.76
Accelerated atherosclerosis in SLE: mechanisms and prevention approaches. Int J Clin Rheumtol (2012) 0.76
Autoreactive CD4+ CD28- T cells and acute coronary syndromes. Arterioscler Thromb Vasc Biol (2007) 0.76
The Roles of CD137 Signaling in Atherosclerosis. Korean Circ J (2016) 0.75
Quantification of Various Inflammatory Cells in Advanced Atherosclerotic Plaques. J Clin Diagn Res (2016) 0.75
Stabilization of high-risk plaques. Cardiovasc Diagn Ther (2016) 0.75
Angiotensin II Promotes the Development of Carotid Atherosclerosis in Type 2 Diabetes Patients via Regulating the T Cells Activities: A Cohort Study. Med Sci Monit (2016) 0.75
CCR5Δ32 genotype leads to a Th2 type directed immune response in ESRD patients. PLoS One (2012) 0.75
Progress and challenges in translating the biology of atherosclerosis. Nature (2011) 9.41
Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol (2009) 6.11
Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med (2006) 4.28
Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation (2002) 3.60
Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest (2002) 2.58
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res (2003) 2.44
Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity (2013) 2.37
Adaptive immunity and atherosclerosis. Clin Immunol (2009) 2.08
Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest (2003) 1.98
Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med (2003) 1.95
Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev (2007) 1.94
T cell-mediated inflammation in adipose tissue does not cause insulin resistance in hyperlipidemic mice. Circ Res (2009) 1.93
Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Circ Cardiovasc Genet (2010) 1.86
Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol (2005) 1.85
Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol (2002) 1.82
CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med (2004) 1.80
Upregulation of the 5-lipoxygenase pathway in human aortic valves correlates with severity of stenosis and leads to leukotriene-induced effects on valvular myofibroblasts. Circulation (2011) 1.78
Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Circ Res (2005) 1.67
CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation (2008) 1.64
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest (2013) 1.61
Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions. Cardiovasc Res (2009) 1.57
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J (2004) 1.54
Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J Exp Med (2010) 1.52
Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol (2006) 1.47
Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc Natl Acad Sci U S A (2005) 1.41
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J (2009) 1.36
Accumulation of foam cells in liver X receptor-deficient mice. Circulation (2002) 1.34
Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation (2011) 1.33
Innate immune signals in atherosclerosis. Clin Immunol (2009) 1.32
Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.31
Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci U S A (2006) 1.28
Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis. Arterioscler Thromb Vasc Biol (2009) 1.25
Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler Thromb Vasc Biol (2004) 1.23
Effect of sex and age on serum biochemical reference ranges in C57BL/6J mice. Comp Med (2004) 1.23
Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells. J Biol Chem (2009) 1.22
Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler Thromb Vasc Biol (2006) 1.22
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol (2006) 1.21
CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2004) 1.21
Chemokines and atherosclerosis. Ann Med (2004) 1.14
Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol (2004) 1.12
5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation. Circ Res (2007) 1.11
Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium. J Mol Cell Cardiol (2007) 1.08
Immunology of ischemic vascular disease: plaque to attack. Trends Immunol (2005) 1.07
Leukotriene receptors in atherosclerosis. Ann Med (2006) 1.07
Highlights of 10 years of immunology in Nature Reviews Immunology. Nat Rev Immunol (2011) 1.06
The use of network analyses for elucidating mechanisms in cardiovascular disease. Mol Biosyst (2009) 1.06
IKKbeta-dependent NF-kappaB pathway controls vascular inflammation and intimal hyperplasia. FASEB J (2005) 1.06
Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci Transl Med (2013) 1.02
Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (2007) 1.02
T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice. Am J Pathol (2009) 1.01
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation. Circulation (2012) 0.99
12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms. Atherosclerosis (2011) 0.95
Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque. Int J Mol Med (2005) 0.95
Vaccination against atherosclerosis: science or fiction? Circulation (2002) 0.93
Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice--brief report. Arterioscler Thromb Vasc Biol (2009) 0.92
Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk. Circ Cardiovasc Genet (2012) 0.92
Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice. Atherosclerosis (2009) 0.92
CARD8 gene encoding a protein of innate immunity is expressed in human atherosclerosis and associated with markers of inflammation. Clin Sci (Lond) (2013) 0.91
Toll to be paid at the gateway to the vessel wall. Arterioscler Thromb Vasc Biol (2005) 0.91
Platelets regulate CD4⁺ T-cell differentiation via multiple chemokines in humans. Thromb Haemost (2011) 0.90
Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis. Cardiovasc Res (2013) 0.88
Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation (2011) 0.88
HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells. Atherosclerosis (2003) 0.88
Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice. Atherosclerosis (2008) 0.87
Lack of invariant natural killer T cells affects lipid metabolism in adipose tissue of diet-induced obese mice. Arterioscler Thromb Vasc Biol (2013) 0.87
Prediction of ischemic events on the basis of transcriptomic and genomic profiling in patients undergoing carotid endarterectomy. Mol Med (2012) 0.87
Valvular osteoclasts in calcification and aortic valve stenosis severity. Int J Cardiol (2013) 0.85
Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe⁻/⁻ mice. Immunobiology (2011) 0.84
Rip2 deficiency leads to increased atherosclerosis despite decreased inflammation. Circ Res (2011) 0.84
Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion. J Mol Med (Berl) (2010) 0.84
NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 0.84
The tryptophan metabolite 3-hydroxyanthranilic acid lowers plasma lipids and decreases atherosclerosis in hypercholesterolaemic mice. Eur Heart J (2012) 0.83
Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis. Circ Res (2008) 0.83
The atheroprotective effect of 17beta-estradiol depends on complex interactions in adaptive immunity. Am J Pathol (2005) 0.82
Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice. Eur J Immunol (2014) 0.82
Deficiency of nitric oxide synthase 2 results in increased neointima formation in a mouse model of vascular injury. J Cardiovasc Pharmacol (2003) 0.81
Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease. PLoS One (2012) 0.81
Two views on plaque rupture. Arterioscler Thromb Vasc Biol (2007) 0.81
Modulation of autoimmunity and atherosclerosis - common targets and promising translational approaches against disease. Circ J (2015) 0.79
Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilization. Atherosclerosis (2012) 0.79
Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions. Atherosclerosis (2006) 0.78
Gene deletion of NF-kappaB p105 enhances neointima formation in a mouse model of carotid artery injury. Cardiovasc Drugs Ther (2006) 0.78
The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis. Thromb Haemost (2009) 0.78
CDR3 sequence preference of TCRBV8S2+ T cells within the CNS does not reflect single amino acid dependent avidity expansion. J Neuroimmunol (2005) 0.77
Fatty acid binding protein 4 in circulating leucocytes reflects atherosclerotic lesion progression in Apoe(-/-) mice. J Cell Mol Med (2013) 0.77
T cell-based therapies for atherosclerosis. Curr Pharm Des (2013) 0.77
Thrombin inhibitor reduces myocardial infarction in apoE-/- x LDLR-/- mice. Am J Physiol Heart Circ Physiol (2004) 0.76
The B cell: a good guy in vascular disease? Arterioscler Thromb Vasc Biol (2002) 0.76
Immunomodulation and vaccination for atherosclerosis. Expert Opin Biol Ther (2004) 0.76
Glimpse of the secret life of the plaque. Arterioscler Thromb Vasc Biol (2004) 0.75
TGF-beta in atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 0.75
Epidemiology complements immunology in the heart. Arterioscler Thromb Vasc Biol (2006) 0.75
Dr Jérémy Fauconnier talks with Prof Göran K. Hansson. Cardiovasc Res (2017) 0.75
Activation of VPAC1 receptors aggravates early atherosclerosis in hypercholesterolemic apolipoprotein E-deficient mice. Biochem Biophys Res Commun (2010) 0.75
Vaccination and atherosclerosis. Curr Atheroscler Rep (2004) 0.75
Letter to the Editor: Autoreactive CD4+CD28- T Cells and Acute Coronary Syndromes. Arterioscler Thromb Vasc Biol (2007) 0.75
ATVB in focus: Smooth muscle cells. Arterioscler Thromb Vasc Biol (2003) 0.75